A citation-based method for searching scientific literature

Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
Times Cited: 128



Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke, Charlie Gourley, Susana Banerjee, Amit Oza, Antonio González-Martín, Carol Aghajanian, William Bradley, Cara Mathews, Joyce Liu, Elizabeth S Lowe, Ralph Bloomfield, Paul DiSilvestro. N Engl J Med 2018
Times Cited: 696




List of shared articles



Times cited

Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population-based testing program.
Melanie Care, Jeanna McCuaig, Blaise Clarke, Sylvie Grenier, Raymond H Kim, Marjan Rouzbahman, Natalie Stickle, Marcus Bernardini, Tracy L Stockley. Mol Oncol 2021
3

The Knowledge and Attitude of Patients Diagnosed with Epithelial Ovarian Cancer towards Genetic Testing.
Wonkyo Shin, Gowoon Jeong, Yedong Son, Sang-Soo Seo, Sokbom Kang, Sang-Yoon Park, Myong Cheol Lim. Int J Environ Res Public Health 2021
0

Outcomes of incidentally detected ovarian cancers diagnosed at time of risk-reducing salpingo-oophorectomy in BRCA mutation carriers.
Renee Cowan, Silvana Pedra Nobre, Nisha Pradhan, Maya Yasukawa, Qin C Zhou, Alexia Iasonos, Robert A Soslow, Angela G Arnold, Magan Trottier, Amanda Catchings,[...]. Gynecol Oncol 2021
0

The Prevent Ovarian Cancer Program (POCP): Identification of women at risk for ovarian cancer using complementary recruitment approaches.
Alicia A Tone, Jeanna M McCuaig, Nicole Ricker, Talin Boghosian, Tina Romagnuolo, Natalie Stickle, Carl Virtanen, Tong Zhang, Raymond H Kim, Sarah E Ferguson,[...]. Gynecol Oncol 2021
0

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition.
Janet R Vos, Ingrid E Fakkert, Joanne A de Hullu, Anne M van Altena, Aisha S Sie, Hicham Ouchene, Riki W Willems, Iris D Nagtegaal, Marjolijn C J Jongmans, Arjen R Mensenkamp,[...]. J Natl Cancer Inst 2020
11

Current Approaches to Germline Cancer Genetic Testing.
Elena M Stoffel, John M Carethers. Annu Rev Med 2020
3

Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic counseling and testing and impact on patient-reported stress, anxiety and depression.
Melissa K Frey, Sarah S Lee, Deanna Gerber, Zachary P Schwartz, Jessica Martineau, Kathleen Lutz, Erin Reese, Emily Dalton, Annie Olsen, Julia Girdler,[...]. Gynecol Oncol 2020
1

Population-based genetic testing for Women's cancer prevention.
Olivia Evans, Faiza Gaba, Ranjit Manchanda. Best Pract Res Clin Obstet Gynaecol 2020
5

Population-based Genetic Testing for Precision Prevention.
Olivia Evans, Ranjit Manchanda. Cancer Prev Res (Phila) 2020
1

Setting a baseline: A 7-year review of referral rates and outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing.
Susan Randall Armel, Alexandra Volenik, Rochelle Demsky, Janet Malcolmson, Manjula Maganti, Jeanna McCuaig. Gynecol Oncol 2020
2

Emerging drugs for the treatment of ovarian cancer: a focused review of PARP inhibitors.
Elizabeth K Lee, Ursula A Matulonis. Expert Opin Emerg Drugs 2020
1

Streamlining genetic testing for women with ovarian cancer in a Northern California health care system.
C Bethan Powell, Cecile Laurent, Giuseppe Ciaravino, Christine Garcia, Liz Han, Elizabeth Hoodfar, Audrey Karlea, Christine Kobelka, Jaimie Lee, Ramey D Littell,[...]. Gynecol Oncol 2020
3


Identifying disparities in germline and somatic testing for ovarian cancer.
Marilyn Huang, Priyanka Kamath, Matthew Schlumbrecht, Feng Miao, Devin Driscoll, Sean Oldak, Brian Slomovitz, Tulay Koru-Sengul, Sophia George. Gynecol Oncol 2019
5

The 34th Annual Meeting of the Korean Society of Gynecologic Oncology 2019: meeting report.
Ga Won Yim, Dong Hoon Suh, Jae Weon Kim, Seung Cheol Kim, Young Tae Kim. J Gynecol Oncol 2019
4

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.
Krishnansu S Tewari, Robert A Burger, Danielle Enserro, Barbara M Norquist, Elizabeth M Swisher, Mark F Brady, Michael A Bookman, Gini F Fleming, Helen Huang, Howard D Homesley,[...]. J Clin Oncol 2019
98

Practical Cancer Genetics and Genomics in Women's Health.
Susan Modesitt, Holly J Pederson, Royce T Adkins. Clin Obstet Gynecol 2019
0